Prothena to Participate in the 36th Annual J.P. Morgan Healthcare Conference

DUBLIN, Ireland, Jan. 03, 2018 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan categories, today announced that members of its senior management team will present and participate in the 36th Annual […] Lire la suite »